Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

34.380
-0.960-2.72%
Volume:4.96M
Turnover:171.96M
Market Cap:208.48B
PE:31.69
High:35.680
Open:35.680
Low:34.140
Close:35.340
52wk High:43.939
52wk Low:27.882
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:0.62
T/O Rate:0.08%
Dividend:0.49
Dividend Rate:1.44%
EPS(LYR):1.085
ROE:19.40%
ROA:9.08%
PB:4.73
PE(LYR):31.69
PS:11.24

Loading ...

Hansoh Pharma transfers KiOmedinevsOne China license to Hengrui for RMB 131 million

Reuters
·
Apr 29

Hansoh Pharmaceutical - Transfers Kiomedinevsone License to Jiangsu Hengrui Pharmaceuticals on April 29, 2026

THOMSON REUTERS
·
Apr 29

Hansoh Pharmaceutical - Transfer Price for Kiomedinevsone License Set at RMB131 Mln

THOMSON REUTERS
·
Apr 29

GSK shares slide as investors question one-off result boost

Reuters
·
Apr 29

Hansoh Pharma Ends Post-IPO RSU Scheme, Seeks Approval for 2026 Share Plan

Bulletin Express
·
Apr 28

Hansoh Pharma Grants 4.99 Million RSUs to 804 Participants under Post-IPO Scheme

Bulletin Express
·
Apr 28

Hansoh Pharma Announces HKD 0.20 Final Dividend for FY2025, Shareholder Vote Set for 26 June 2026

Bulletin Express
·
Apr 28

HANSOH PHARMA (03692) Awards 4.9923 Million Shares in Restricted Stock Units

Stock News
·
Apr 28

Hansoh Pharmaceutical grants 4,992,330 RSUs under post-IPO scheme at HK$ 7.86

Reuters
·
Apr 28

Hansoh Pharma updates shareholder approval date for HKD 0.2 final dividend

Reuters
·
Apr 28

Hansoh Pharma publishes 2025 ESG report

Reuters
·
Apr 28

Hansoh Pharmaceutical Group Stock Slips 1.9% in Hong Kong

Dow Jones
·
Apr 27

Hansoh Pharmaceutical Group Stock Climbs 1.6% in Hong Kong

Dow Jones
·
Apr 24

Biopharma Stocks Slide Across Board as Oil Prices Squeeze Rate Cut Prospects

Stock News
·
Apr 23

Hansoh Pharmaceutical Group Stock Climbs 1.5% in Hong Kong

Dow Jones
·
Apr 22

Hansoh says phase 1 HS-10504 shows 52.9% ORR in EGFR C797S NSCLC

Reuters
·
Apr 22

Hua Yuan Securities Reiterates "Buy" on Hansoh Pharma with Innovation Pipeline Nearing Fruition

Stock News
·
Apr 21

Hansoh Pharmaceutical Group Stock Slides 2.2% in Hong Kong

Dow Jones
·
Apr 21

CMB International Reports Moderate Recovery in Healthcare Sector Risk Appetite, Recommends Six Stocks Including Hansoh Pharma

Stock News
·
Apr 20

Hansoh combo trial shows 47.1% response rate in previously treated non-squamous NSCLC

Reuters
·
Apr 20